Financial Ratios Quanterix Corporation
Equities
QTRX
US74766Q1013
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.800 USD | +1.69% |
|
-5.10% | -23.90% |
| Mar. 02 | Quanterix Corporation, Q4 2025 Earnings Call, Mar 02, 2026 | |
| Mar. 02 | Quanterix Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -9.43 | -9.5 | -6.47 | -7.42 | -13.11 | |||||
Return on Total Capital | -10.42 | -10.26 | -7.02 | -8.17 | -15.45 | |||||
Return On Equity % | -17.83 | -24.18 | -9.16 | -11.33 | -34.25 | |||||
Return on Common Equity | -17.83 | -24.18 | -9.16 | -11.33 | -34.25 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 56.08 | 44.36 | 57.73 | 60.47 | 46.77 | |||||
SG&A Margin | 83.52 | 87.18 | 73.75 | 73.95 | 86.9 | |||||
EBITDA Margin % | -48.36 | -62.29 | -31.13 | -31.39 | -51.78 | |||||
EBITA Margin % | -50.93 | -65.65 | -35.02 | -34.93 | -56.86 | |||||
EBIT Margin % | -52.74 | -67.36 | -36.33 | -36.09 | -62.33 | |||||
Income From Continuing Operations Margin % | -52.18 | -91.64 | -26.42 | -28.04 | -77.14 | |||||
Net Income Margin % | -52.18 | -91.64 | -26.42 | -28.04 | -77.14 | |||||
Net Avail. For Common Margin % | -52.18 | -91.64 | -26.42 | -28.04 | -77.14 | |||||
Normalized Net Income Margin | -33.66 | -39.1 | -14.61 | -16.16 | -35.03 | |||||
Levered Free Cash Flow Margin | -35.55 | -31.09 | -12.17 | -12.53 | -5.06 | |||||
Unlevered Free Cash Flow Margin | -35.32 | -31.09 | -12.17 | -12.53 | -5.06 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.29 | 0.23 | 0.28 | 0.33 | 0.34 | |||||
Fixed Assets Turnover | 3.99 | 2.98 | 3.16 | 3.95 | 3.76 | |||||
Receivables Turnover (Average Receivables) | 5.4 | 4.93 | 5.51 | 4.78 | 4.47 | |||||
Inventory Turnover (Average Inventory) | 2.62 | 3.01 | 2.64 | 1.84 | 1.69 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 12.14 | 12.32 | 9.84 | 8.66 | 2.84 | |||||
Quick Ratio | 11.37 | 11.56 | 9.02 | 7.65 | 1.98 | |||||
Operating Cash Flow to Current Liabilities | -1.3 | -1.56 | -0.49 | -0.84 | -1.03 | |||||
Days Sales Outstanding (Average Receivables) | 67.63 | 74.03 | 66.26 | 76.64 | 81.61 | |||||
Days Outstanding Inventory (Average Inventory) | 139.25 | 121.14 | 138.14 | 198.43 | 216.07 | |||||
Average Days Payable Outstanding | 52.27 | 44.66 | 28.29 | 36.02 | 39.04 | |||||
Cash Conversion Cycle (Average Days) | 154.6 | 150.52 | 176.11 | 239.06 | 258.64 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 4.96 | 12.29 | 11.95 | 11.32 | 12.59 | |||||
Total Debt / Total Capital | 4.73 | 10.94 | 10.68 | 10.17 | 11.18 | |||||
LT Debt/Equity | 4.64 | 11.54 | 10.73 | 9.88 | 9.92 | |||||
Long-Term Debt / Total Capital | 4.42 | 10.28 | 9.58 | 8.88 | 8.81 | |||||
Total Liabilities / Total Assets | 12.08 | 17.33 | 18.37 | 18.82 | 29.38 | |||||
EBIT / Interest Expense | -144.69 | - | - | - | - | |||||
EBITDA / Interest Expense | -119.26 | - | - | - | - | |||||
(EBITDA - Capex) / Interest Expense | -153.04 | - | - | - | - | |||||
Total Debt / EBITDA | -0.46 | -0.78 | -1.44 | -1.1 | -0.62 | |||||
Net Debt / EBITDA | 7.79 | 5.18 | 9.69 | 7.44 | 1.34 | |||||
Total Debt / (EBITDA - Capex) | -0.35 | -0.64 | -1.27 | -1 | -0.59 | |||||
Net Debt / (EBITDA - Capex) | 6.07 | 4.3 | 8.57 | 6.77 | 1.29 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 27.99 | -4.55 | 15.96 | 12.3 | 1.07 | |||||
Gross Profit, 1 Yr. Growth % | 26.79 | -24.51 | 50.93 | 11.96 | -21.83 | |||||
EBITDA, 1 Yr. Growth % | 101.36 | 22.95 | -42.05 | 24.39 | 71.12 | |||||
EBITA, 1 Yr. Growth % | 95.78 | 23.03 | -38.15 | 21.97 | 68.4 | |||||
EBIT, 1 Yr. Growth % | 88.94 | 21.9 | -37.46 | 21.11 | 78.51 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 82.96 | 67.63 | -66.56 | 35.89 | 178.09 | |||||
Net Income, 1 Yr. Growth % | 82.96 | 67.63 | -66.56 | 35.89 | 178.09 | |||||
Normalized Net Income, 1 Yr. Growth % | 90.96 | 10.66 | -56.08 | 40.41 | 129.12 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 49.77 | 63.12 | -67.1 | 33.15 | 150.23 | |||||
Accounts Receivable, 1 Yr. Growth % | 38.42 | -20.05 | 33.64 | 26.47 | -6.75 | |||||
Inventory, 1 Yr. Growth % | 49.37 | -24.35 | 33.24 | 25.46 | 67.09 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 13.68 | 40.52 | -12.58 | -7.43 | 20.45 | |||||
Total Assets, 1 Yr. Growth % | 85.03 | -13.42 | -2.12 | -5.14 | 3.01 | |||||
Tangible Book Value, 1 Yr. Growth % | 131.27 | -16.48 | -3 | -5.21 | -57.8 | |||||
Common Equity, 1 Yr. Growth % | 113.92 | -18.6 | -3.35 | -5.69 | -10.4 | |||||
Cash From Operations, 1 Yr. Growth % | 105.04 | 0.76 | -60.84 | 86.56 | 119.64 | |||||
Capital Expenditures, 1 Yr. Growth % | 246.46 | -13.88 | -67.7 | -12.31 | -22.45 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 218.1 | -16.52 | -53.61 | 6.06 | -57.44 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 220.49 | -15.98 | -53.61 | 6.06 | -57.44 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 39.59 | 10.53 | 5.21 | 14.12 | 6.54 | |||||
Gross Profit, 2 Yr. CAGR % | 50.3 | -2.17 | 6.98 | 35.35 | -6.45 | |||||
EBITDA, 2 Yr. CAGR % | 21.73 | 57.34 | -15.81 | -20.29 | 44.02 | |||||
EBITA, 2 Yr. CAGR % | 22.23 | 55.2 | -12.98 | -18.07 | 41.66 | |||||
EBIT, 2 Yr. CAGR % | 22.14 | 51.76 | -12.89 | -17.74 | 45.4 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 18.91 | 75.13 | -25.13 | -37.79 | 94.4 | |||||
Net Income, 2 Yr. CAGR % | 18.91 | 75.13 | -25.13 | -37.79 | 94.4 | |||||
Normalized Net Income, 2 Yr. CAGR % | 24.41 | 45.49 | -30.12 | -28.32 | 85.62 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -0.85 | 56.63 | -26.74 | -38.92 | 82.53 | |||||
Accounts Receivable, 2 Yr. CAGR % | 47.68 | 5.2 | 3.37 | 30 | 8.6 | |||||
Inventory, 2 Yr. CAGR % | 45.63 | 6.3 | 0.39 | 39 | 44.79 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 56.35 | 26.39 | 10.83 | -9.66 | 5.59 | |||||
Total Assets, 2 Yr. CAGR % | 71.78 | 26.57 | -7.94 | -3.17 | -1.15 | |||||
Tangible Book Value, 2 Yr. CAGR % | 100.19 | 38.98 | -9.99 | -3.55 | -36.76 | |||||
Common Equity, 2 Yr. CAGR % | 85.13 | 31.96 | -11.3 | -3.98 | -8.07 | |||||
Cash From Operations, 2 Yr. CAGR % | 35.26 | 43.74 | -37.19 | -14.95 | 102.43 | |||||
Capital Expenditures, 2 Yr. CAGR % | 12.04 | 72.73 | -47.26 | -46.15 | -17.54 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 9.65 | 62.96 | -38.19 | -27.88 | -34.17 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 9.3 | 64.1 | -37.99 | -27.88 | -34.17 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 43.22 | 22.98 | 12.31 | 7.52 | 9.59 | |||||
Gross Profit, 3 Yr. CAGR % | 51.17 | 19.47 | 13.04 | 8.66 | 12.71 | |||||
EBITDA, 3 Yr. CAGR % | 21.11 | 22.13 | 12.78 | -5.82 | 1.95 | |||||
EBITA, 3 Yr. CAGR % | 22.21 | 22.5 | 14.21 | -4.16 | 3.37 | |||||
EBIT, 3 Yr. CAGR % | 22.85 | 22.06 | 12.93 | -4.26 | 5.7 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 22.3 | 33.33 | 0.84 | -11.48 | 2.47 | |||||
Net Income, 3 Yr. CAGR % | 22.3 | 33.33 | 0.84 | -11.48 | 2.47 | |||||
Normalized Net Income, 3 Yr. CAGR % | 23.76 | 19.72 | -2.83 | -14.73 | 4.02 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 3.78 | 17.05 | -6.89 | -13.34 | -2.27 | |||||
Accounts Receivable, 3 Yr. CAGR % | 51.86 | 20.36 | 13.93 | 10.56 | 16.37 | |||||
Inventory, 3 Yr. CAGR % | 55.12 | 17.07 | 14.61 | 13.88 | 47.79 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 115.99 | 50.89 | 11.77 | 4.38 | -0.57 | |||||
Total Assets, 3 Yr. CAGR % | 95.03 | 36.71 | 16.18 | -6.76 | -1.15 | |||||
Tangible Book Value, 3 Yr. CAGR % | 124.06 | 49.58 | 23.28 | -8.16 | -26.78 | |||||
Common Equity, 3 Yr. CAGR % | 120.62 | 40.78 | 18.95 | -9.21 | -6.16 | |||||
Cash From Operations, 3 Yr. CAGR % | 18.6 | 22.61 | -6.82 | -9.61 | 16.69 | |||||
Capital Expenditures, 3 Yr. CAGR % | 107.77 | 2.63 | -1.22 | -37.32 | -39.19 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 32.26 | 0.13 | 6.42 | -23.01 | -40.32 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 31.98 | 0.13 | 6.91 | -22.83 | -40.32 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 44.44 | 35.77 | 26.6 | 19.36 | 9.97 | |||||
Gross Profit, 5 Yr. CAGR % | 51.58 | 36.2 | 31.53 | 24.8 | 5.84 | |||||
EBITDA, 5 Yr. CAGR % | 20.24 | 20.83 | 4.82 | 3.64 | 22.06 | |||||
EBITA, 5 Yr. CAGR % | 21 | 21.65 | 6.79 | 4.95 | 22.39 | |||||
EBIT, 5 Yr. CAGR % | 21.85 | 22.27 | 7.17 | 4.88 | 22.91 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 20.01 | 29.05 | 0.5 | -1.14 | 27.72 | |||||
Net Income, 5 Yr. CAGR % | 20.01 | 29.05 | 0.5 | -1.14 | 27.72 | |||||
Normalized Net Income, 5 Yr. CAGR % | 20.78 | 19.56 | -1.85 | -1.57 | 20.08 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -34.09 | -20.63 | -9.72 | -9.23 | 18.72 | |||||
Accounts Receivable, 5 Yr. CAGR % | 43.44 | 27.7 | 30.2 | 24.13 | 11.77 | |||||
Inventory, 5 Yr. CAGR % | 70.77 | 36.28 | 30.34 | 25.65 | 29.81 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 88.94 | 85.7 | 65.39 | 22.69 | 9.26 | |||||
Total Assets, 5 Yr. CAGR % | 68.32 | 36.45 | 44.44 | 19.06 | 9.09 | |||||
Tangible Book Value, 5 Yr. CAGR % | 29.6 | 39.78 | 55.57 | 25.43 | -5.44 | |||||
Common Equity, 5 Yr. CAGR % | 30.81 | 40.37 | 53.23 | 20.73 | 7.49 | |||||
Cash From Operations, 5 Yr. CAGR % | 21.98 | 16.91 | -8.03 | 6.07 | 27.01 | |||||
Capital Expenditures, 5 Yr. CAGR % | 91.7 | 59.61 | 20.07 | -20.86 | -7.85 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 28.17 | 17.41 | -2.6 | -12.04 | -10.66 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 29.91 | 18.38 | -2.6 | -12.04 | -10.41 |
- Stock Market
- Equities
- QTRX Stock
- Financials Quanterix Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















